Seminars in Radiation Oncology
Volume 16, Issue 1 , Pages 38-44 , January 2006

Radiation Combined With EGFR Signal Inhibitors: Head and Neck Cancer Focus

  • Paul M. Harari, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Paul M. Harari, MD, Department of Human Oncology, University of Wisconsin Comprehensive Cancer Center, 600 Highland Avenue, Madison, WI 53792
    • ,
  • Shyhmin Huang, PhD

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Harari holds research and consulting agreements with AstraZeneca, Genentech, ImClone, Bristol-Myers and Amgen.

PII: S1053-4296(05)00049-4

doi: 10.1016/j.semradonc.2005.08.005

Seminars in Radiation Oncology
Volume 16, Issue 1 , Pages 38-44 , January 2006

Article Tools

* Image Usage & Resolution